Je was op zoek naar: asqol (IJslands - Engels)

hjá sjúklingum sem fengu meðferð með humira kom fram marktækt meiri bati í viku 12, sem hélst út viku 24, bæði hvað varðar sf36 og asqol (ankylosing spondylitis quality of life questionnaire).
humira treated patients had significantly greater improvement at week 12 which was maintained through week 24 in both the sf36 and ankylosing spondylitis quality of life questionnaire (asqol).

sjúklingar sem fengu meðferð með simponi fengu marktækt meiri aukningu í heilbrigðistengdum lífsgæðum, metið með asqol, eq-5d og í líkamlegum og huglægum þáttum sf-36 og fengu marktækt meiri bata í afköstum, mælt sem meiri minnkun í heildarskerðingu starfsgetu samkvæmt wpai spurningalista, en sjúklingar sem fengu lyfleysu.
patients treated with simponi experienced significantly more improvements in health-related quality of life as assessed by asqol, eq-5d, and physical and mental components of sf-36, and experienced significantly more improvements in productivity as assessed by greater reductions in overall work impairment and in activity impairment as assessed by the wpai questionnaire than patients receiving placebo.